EU MDR Annex VII: Timelines and What’s Changing

MedTech Leading Voice | Issue 159

📝 From the Editor

Before we get into this week’s issue, for the pet lovers out there, Andre DiMino’s Vet-Sonotron has made it to the Top 8 in the “Coolest Thing Made in New Jersey” competition. It’s a non-invasive therapy device designed to help pets, especially older dogs, manage arthritis and move more comfortably.

👉 Voting closes tomorrow (Monday) at midnight, and you can vote up to five times.

✈️ I’ll be in Boston tomorrow at the BSI Roadshow.

If you’re working under MDR right now, you already know where the pressure is: timelines, Notified Bodies, and what actually happens once your submission is “ready.”

That’s the focus this week.

— Sean Smith

🎯 Featured Event

BSI 15th Annual Medical Device Roadshow — Annex VII Timelines and Review Processes

Regulatory expectations are evolving fast, and even experienced RA/QA teams are feeling the pressure.

Thanks to Richard Holborow, I will be attending this week’s BSI Roadshow (Boston), which will bring direct insight from a Notified Body, including expectations, lessons learned, and what is happening across submissions right now. The sessions will cover:

• EU and UK regulatory updates
• QMS best practices
• Breakthrough Device pathway
• AI and medical devices
• Annex VII timelines and review processes
• Clinical evaluation expectations

I’ll be in Burlington (Boston) tomorrow and hope to share updates from the floor.

Stops this week:

• April 13 — Burlington, MA
• April 15 — Minneapolis, MN
• April 17 — Santa Clara, CA

There's still time to register >>

🧠 Featured Article

Caroline Shleifer on the Regulatory Problem That Shows Up Too Late

Recently, I spoke with Caroline Shleifer, CEO of RegASK, about a pattern most teams recognize:

• The regulatory question shows up after the decision is already made.
• What looks like monitoring is actually a system of interpretation, communication, and execution across markets.
• That gap is where time gets lost.

Read the article >>

🛠️ Ask an Engineer

The Retry Amplification Trap

Last week, I asked Mark Omo why streaming keeps buffering even with full bars when I’m trying to watch The Pitt on HBO Max. He explained that retries create more congestion, which creates more failures. Systems become saturated quickly under load.

This infographic lays it out clearly—and it’s a useful way to think about connected medical devices, where the same behavior can affect performance, data flow, and reliability.

📌 This Week’s Top Posts (In no special order)

• Health Canada guidance on terms and conditions for Class II to IV medical devices and lifecycle oversight outlined by Stefano Bolletta.
• In her weekly Monday News, Marina Daineko covered MHRA biological safety updates, FDA enforcement actions, and growing use of real world evidence.
• Intrinsic Medical Group broke down key considerations to address when defining reprocessing requirements during the design and development phase.
• Basic principles to software risk management for medical devices explained by EU MDR Compliance.
• QMSR core principles and FDA expectations for ISO 13485 alignment are summarized by Matrix One.
• Mario Gabrielli Cossellu shared updates on new MDR harmonised standards references published in the OJEU.
• FDA AI framework gaps, transparency expectations, and lifecycle oversight considerations discussed by Vanessa Rivell.
• Yujan Shrestha announced the FDA’s wearable AI program, including early engagement opportunities and application timelines.
• Useful guidance on interpreting “significant change” for medical devices in Canada underscored by Jean-Luc Leneindre.
• Dolly Sharma noted a major PMD Act update in Japan, signaling a broader structural shift in medical device regulation effective 2026.
• Key ISO 14155:2026 risk management updates for clinical investigations highlighted by MDx CRO.

💥 Weekly 510(k) Roundup

April 06, 2026 | From Marcus Engineering, LLC

64 total clearances this week across multiple categories, including 7 first-time clearances (🚀).

Featured first-time clearances:

• 🚀 Verge Medical, Inc.– FLASH Flex™ Aorto Ostial Angioplasty System: Designed for blockages at the opening of major arteries, the system provides greater control and precision in one of the most complex and high-risk treatment areas.
• 🚀 Magentiq Eye Ltd. – MAGENTIQ COLO (ME APDS): Enhances visibility during colonoscopy procedures, helping clinicians detect small or hard-to-see polyps and improve early cancer detection.
• 🚀 Becton, Dickinson and Company– Onclarity™ Self Collection Kit: Enables patients to collect their own cervical cancer screening sample, expanding access and supporting earlier detection.

Full breakdown available in the April 06, 2026, 510(k) Roundup.

📋 Regulatory Roundup

April 06, 2026 | By Martin King

Regulators across the FDA, EMA, MHRA, TGA, HSA, MDA, Swissmedic, and other authorities continue advancing lifecycle-based oversight built on continuous monitoring, data-driven decision-making, and supply chain resilience.

This week’s updates reinforce tightening pharmacovigilance expectations, expanded reliance pathways, rising GMP and submission standards, and increasing focus on real-world evidence, AI integration, and data governance across global regulatory systems.

Explore the update >>

🗓️ Upcoming Events & Webinars

• April 17, 2026 | 11:00 AM ET - Global Regulatory Submissions Made Simple – Leveraging AI and Existing Market Approvals, Featuring Oliver Eikenberg, Pure Global. Focused on using existing approvals, structured documentation, and AI-assisted workflows to reduce submission timelines across markets.
• April 24, 2026 | 11:00 AM ET - AI/ML FDA Submissions: Common Pitfalls, Hard Lessons, and Faster Paths Forward,Featuring Leon Doorn, MedQAIR. A practical look at where AI submissions slow down and how to avoid avoidable delays.
• Friday, May 1, 2026 | 11:00 AM ET: EUDAMED Is Coming Fast: How to Turn Existing Documentation into Submission-Ready Files, featuring Sam Patton from EUDAPrep. Focused on taking existing documentation and preparing it for EUDAMED without rebuilding from scratch. IMSC26 – International MedTech Safety Conference 2026

IMSC26 – International MedTech Safety Conference 2026

Join me, June 2–5, 2026 | Boston - IMSC26, featuring Dr. Michelle Tarver, FDA Director of CDRH, and a host of expert speakers. IMSC26 brings together MedTech professionals, regulators, and technical experts focused on safety, risk, and AI. Virtual or In-person.

Special MLV Discount Codes:

• $200 off General Registration (in-person OR virtual): MLV$200
• Startup: Start$250 – $250 off in-person registration
• Startup Education Day: StartEd$50 – $50 off

Register Now >>

In Case You Missed It

PMCF Surveys Under MDR: When They Apply, How to Structure Them, and What Good Looks Like. Last Friday, more than 200 attendees joined Marcus Torr from Purdie Pascoe for a strong session, practical discussion, and detailed Q&A on real-world PMCF execution.

Catch the replay >>

🔥 Postscript

Coming up: May 30, 2026 | 12:00 PM ET: Why MedTech Launches Stall: Aligning Regulatory, Reimbursement, and Commercial Strategy Earlier. Featuring Michelle Lott, RAC, Renae Franz, and Fernanda Nusbaum. Registration coming soon.

Sean 🐝